HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • #Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #Global Trends

    GSK licenses Halozyme ENHANZE for subcutaneous cancer drugs, including ADCs

    08/05/2026 Published by ViNe

    Halozyme Therapeutics Inc. and GSK have entered into a global collaboration and license agreement. Under the terms, GSK has licensed... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Altasciences and Certara partner to accelerate early-phase drug development

    08/05/2026 Published by ViNe

    Altasciences, an integrated drug development solution company, and Certara, a global leader in model-informed drug development, have launched a strategic... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Blackstone Life Sciences invests $250M in Anagram Therapeutics for Pancreatic Enzyme Replacement Therapy

    08/05/2026 Published by ViNe

    Blackstone Life Sciences is making a $250 million investment in Anagram Therapeutics, a clinical-stage biopharmaceutical company. The funding is designated... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Eli Lilly pledges additional $4.5B to build the largest API manufacturing site in US history

    08/05/2026 Published by ViNe

    Pharmaceutical giant Eli Lilly has unveiled plans to invest an additional $4.5 billion into its Lebanon campus in Indiana. This... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Novo Nordisk kicks off 2026 with a strong start led by oral obesity “Trump Card”

    08/05/2026 Published by ViNe

    After a period of volatility, Danish pharmaceutical giant Novo Nordisk reported positive signals in Q1 2026. The most significant highlight... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Sanofi requests to withdraw Tzield application from FDA’s controversial CNPV program

    08/05/2026 Published by ViNe

    French pharmaceutical giant Sanofi has reportedly requested to remove its application for the expanded use of the diabetes drug Tzield... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Pfizer scuttles $2.3B Trillium investment and exits current T-cell engager modality

    06/05/2026 Published by ViNe

    Pfizer has announced a major trimming of its clinical pipeline, marked by the total collapse of its $2.3 billion Trillium... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Sanofi invests $294M to scale its global AI hub in Toronto

    06/05/2026 Published by ViNe

    French pharmaceutical giant Sanofi is investing $294 million to expand its global AI center of excellence in Toronto, Canada. This... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Novartis to shutter German plant as part of shift toward advanced medical modalities

    06/05/2026 Published by ViNe

    The Swiss pharmaceutical giant Novartis has announced plans to close its manufacturing facility in Wehr, Germany, by the end of... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 37 Page 38 Page 39 … Page 92 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved